Drug Patent Expirations for February 25 2014

If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
body { font-family:Calibri, tahoma, arial,
sans-serif;}table { font-size:12px; font-family:Calibri, tahoma, arial,
sans-serif; border-collapse:collapse; margin: 0px auto;}.xsnazzy h1,
.zsnazzy h1 { margin:0; font-size:1.2em; padding:0 10px 5px 10px;
border-bottom:1px solid #444; }.xsnazzy { background: transparent; margin:0
3px;}.xtop, .xbottom { display:block; background:transparent;
font-size:1px; }.xb1, .xb2, .xb3, .xb4 { display:block; overflow:hidden;
}.xb1, .xb2, .xb3 { height:1px; }.xb2, .xb3, .xb4 { background:#fff;
border-left:1px solid #444; border-right:1px solid #444; }.xb1 { margin:0
5px; background:#444; }.xb2 { margin:0 3px; border-width:0 2px; }.xb3 {
margin:0 2px; }.xb4 { height:2px; margin:0 1px;}.xboxcontent {
display:block; border:0 solid #444; border-width:0 1px; height:auto; }*
html .xboxcontent { height:1px; } td { padding:3px; } tr { border:.5pt;
background-color:#FFF; }

Journal of Commercial Biotechnology

Advertise
here

This newsletter is
a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents

Drug Patent Expirations for February 25 2014

Tradename Applicant Generic Name Patent
Expiration
ALVESCO

Takeda Gmbh

ciclesonide

Feb 25, 2014
IMAGENT

Imcor Pharms Co

dimyristoyl lecithin; perflexane

Feb 25, 2014
MYLOTARG

Wyeth Pharms Inc

gemtuzumab ozogamicin

Feb 25, 2014
PROAIR HFA

Teva Branded Pharm

albuterol sulfate

Feb 25, 2014
PROVENTIL-HFA

3m

albuterol sulfate

Feb 25, 2014
QNASL

Teva Branded Pharm

beclomethasone dipropionate

Feb 25, 2014
QVAR
40

Teva Branded Pharm

beclomethasone dipropionate

Feb 25, 2014
QVAR
80

Teva Branded Pharm

beclomethasone dipropionate

Feb 25, 2014
XOPENEX HFA

Sunovion

levalbuterol tartrate

Feb 25, 2014
ZETONNA

Takeda Gmbh

ciclesonide

Feb 25, 2014

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.





Instant Access to Deep Knowledge on Small-Molecule
Drugs

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent data
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Formulation
  • Suppliers
  • Dynamic search capabilities with data
    export
  • More…

More than 6,400 small-molecule drugs from
1,700 branded and generic pharmaceutical companies and 700 suppliers, and
more than 80,000 U.S. and international patents.

See the Database
Preview
and Plan
Comparison
. Contact Us with any
questions.





The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details

DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.


Comments are closed.